Related references
Note: Only part of the references are listed.High-yield genome engineering in primary cells using a hybrid ssDNA repair template and small-molecule cocktails
Brian R. Shy et al.
NATURE BIOTECHNOLOGY (2023)
CD19/22 CAR T cells in children and young adults with B-ALL: phase 1 results and development of a novel bicistronic CAR
Haneen Shalabi et al.
BLOOD (2022)
Long-term activity of tandem CD19/CD20 CAR therapy in refractory/relapsed B-cell lymphoma: a single-arm, phase 1-2 trial
Yajing Zhang et al.
LEUKEMIA (2022)
PSMA-targeting TGFβ-insensitive armored CAR T cells in metastatic castration-resistant prostate cancer: a phase 1 trial
Vivek Narayan et al.
NATURE MEDICINE (2022)
The Tabula Sapiens: A multiple-organ, single-cell transcriptomic atlas of humans
Robert C. Jones et al.
SCIENCE (2022)
CAR T-cells that target acute B-lineage leukemia irrespective of CD19 expression
Kristen Fousek et al.
LEUKEMIA (2021)
Pasotuxizumab, a BiTE® immune therapy for castration-resistant prostate cancer: Phase I, dose-escalation study findings
Horst-Dieter Hummel et al.
IMMUNOTHERAPY (2021)
Targeting a neoantigen derived from a common TP53 mutation
Emily Han-Chung Hsiue et al.
SCIENCE (2021)
T cell circuits that sense antigen density with an ultrasensitive threshold
Rogelio A. Hernandez-Lopez et al.
SCIENCE (2021)
Bispecific antibodies targeting mutant RAS neoantigens
Jacqueline Douglass et al.
SCIENCE IMMUNOLOGY (2021)
An Elaborate New Linker System Significantly Enhances the Efficacy of an HER2-Antibody-Drug Conjugate against Refractory HER2-Positive Cancers
Seol Hwa Shin et al.
ADVANCED SCIENCE (2021)
Discovery of amivantamab (JNJ-61186372), a bispecific antibody targeting EGFR and MET
Joost Neijssen et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2021)
SynNotch-CAR T cells overcome challenges of specificity, heterogeneity, and persistence in treating glioblastoma
Joseph H. Choe et al.
SCIENCE TRANSLATIONAL MEDICINE (2021)
Amivantamab in EGFR Exon 20 Insertion-Mutated Non-Small-Cell Lung Cancer Progressing on Platinum Chemotherapy: Initial Results From the CHRYSALIS Phase I Study
Keunchil Park et al.
JOURNAL OF CLINICAL ONCOLOGY (2021)
CAR T cells with dual targeting of CD19 and CD22 in adult patients with recurrent or refractory B cell malignancies: a phase 1 trial
Jay Y. Spiegel et al.
NATURE MEDICINE (2021)
The Cancer Surfaceome Atlas integrates genomic, functional and drug response data to identify actionable targets
Zhongyi Hu et al.
NATURE CANCER (2021)
NOT-Gated CD93 CAR T Cells Effectively Target AML with Minimized Endothelial Cross-Reactivity
Rebecca M. Richards et al.
BLOOD CANCER DISCOVERY (2021)
A phase II basket study of MCLA-128, a bispecific antibody targeting the HER3 pathway, in NRG1 fusion-positive advanced solid tumors.
Alison M. Schram et al.
JOURNAL OF CLINICAL ONCOLOGY (2020)
Engineered T cells directed at tumors with defined allelic loss
Agnes E. Hamburger et al.
MOLECULAR IMMUNOLOGY (2020)
Designed protein logic to target cells with precise combinations of surface antigens
Marc J. Lajoie et al.
SCIENCE (2020)
Discriminatory Power of Combinatorial Antigen Recognition in Cancer T Cell Therapies
Ruth Dannenfelser et al.
CELL SYSTEMS (2020)
Precise T cell recognition programs designed by transcriptionally linking multiple receptors
Jasper Z. Williams et al.
SCIENCE (2020)
Single-cell transcriptome profiling of an adult human cell atlas of 15 major organs
Shuai He et al.
GENOME BIOLOGY (2020)
Logic-Gated ROR1 Chimeric Antigen Receptor Expression Rescues T Cell-Mediated Toxicity to Normal Tissues and Enables Selective Tumor Targeting
Shivani Srivastava et al.
CANCER CELL (2019)
Anti-BCMA CAR T-Cell Therapy bb2121 in Relapsed or Refractory Multiple Myeloma
Noopur Raje et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
CAR-T cells secreting BiTEs circumvent antigen escape without detectable toxicity
Bryan D. Choi et al.
NATURE BIOTECHNOLOGY (2019)
Universal Chimeric Antigen Receptors for Multiplexed and Logical Control of T Cell Responses
Jang Hwan Cho et al.
CELL (2018)
Tisagenlecleucel in Children and Young Adults with B-Cell Lymphoblastic Leukemia
S. L. Maude et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Osimertinib in Untreated EGFR-Mutated Advanced Non-Small-Cell Lung Cancer
J. -C. Soria et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Different Toxicity of Cetuximab and Panitumumab in Metastatic Colorectal Cancer Treatment: A Systematic Review and Meta-Analysis
Fausto Petrelli et al.
ONCOLOGY (2018)
Enhancing the Potency and Specificity of Engineered T Cells for Cancer Treatment
Sujita Sukumaran et al.
CANCER DISCOVERY (2018)
Strategies to Address Chimeric Antigen Receptor Tonic Signaling
Adam Ajina et al.
MOLECULAR CANCER THERAPEUTICS (2018)
Reprogramming human T cell function and specificity with non-viral genome targeting
Theodore L. Roth et al.
NATURE (2018)
Genetic mechanisms of target antigen loss in CAR19 therapy of acute lymphoblastic leukemia
Elena J. Orlando et al.
NATURE MEDICINE (2018)
Combined Analysis of Antigen Presentation and T-cell Recognition Reveals Restricted Immune Responses in Melanoma
Shelly Kalaora et al.
CANCER DISCOVERY (2018)
Single-cell transcriptomics of 20 mouse organs creates a Tabula Muris
Nicholas Schaum et al.
NATURE (2018)
Systematically benchmarking peptide-MHC binding predictors: From synthetic to naturally processed epitopes
Weilong Zhao et al.
PLOS COMPUTATIONAL BIOLOGY (2018)
Targeting a CAR to the TRAC locus with CRISPR/Cas9 enhances tumour rejection
Justin Eyquem et al.
NATURE (2017)
Genetic effects on gene expression across human tissues
Francois Aguet et al.
NATURE (2017)
Axicabtagene Ciloleucel CAR T-Cell Therapy in Refractory Large B-Cell Lymphoma
S. S. Neelapu et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
A pathology atlas of the human cancer transcriptome
Mathias Uhlen et al.
SCIENCE (2017)
A single dose of peripherally infused EGFRvIII-directed CAR T cells mediates antigen loss and induces adaptive resistance in patients with recurrent glioblastoma
Donald M. O'Rourke et al.
SCIENCE TRANSLATIONAL MEDICINE (2017)
Enhanced tumor-targeting selectivity by modulating bispecific antibody binding affinity and format valence
Yariv Mazor et al.
SCIENTIFIC REPORTS (2017)
tandem CD19/CD20 CAR lentiviral vector drives on-target and off-target antigen modulation in leukemia cell lines
Dina Schneider et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2017)
The clinical efficacy of first-generation carcinoembryonic antigen (CEACAM5)-specific CAR T cells is limited by poor persistence and transient pre-conditioning-dependent respiratory toxicity
Fiona C. Thistlethwaite et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2017)
Integrating Proteomics and Transcriptomics for Systematic Combinatorial Chimeric Antigen Receptor Therapy of AML
Fabiana Perna et al.
CANCER CELL (2017)
Unravelling biology and shifting paradigms in cancer with single-cell sequencing
Timour Baslan et al.
NATURE REVIEWS CANCER (2017)
Precision Tumor Recognition by T Cells With Combinatorial Antigen-Sensing Circuits
Kole T. Roybal et al.
CELL (2016)
Engineering Customized Cell Sensing and Response Behaviors Using Synthetic Notch Receptors
Leonardo Morsut et al.
CELL (2016)
CD19 CAR-T cells of defined CD4+: CD8+ composition in adult B cell ALL patients
Cameron J. Turtle et al.
JOURNAL OF CLINICAL INVESTIGATION (2016)
Tandem CAR T cells targeting HER2 and IL13Rα2 mitigate tumor antigen escape (Publication with Expression of Concern. See vol. 129, pg. 3464, 2019)
Meenakshi Hegde et al.
JOURNAL OF CLINICAL INVESTIGATION (2016)
Dual CD19 and CD123 targeting prevents antigen-loss relapses after CD19-directed immunotherapies
Marco Ruella et al.
JOURNAL OF CLINICAL INVESTIGATION (2016)
Distinct patterns of somatic genome alterations in lung adenocarcinomas and squamous cell carcinomas
Joshua D. Campbell et al.
NATURE GENETICS (2016)
T Cells Expressing CD19/CD20 Bispecific Chimeric Antigen Receptors Prevent Antigen Escape by Malignant B Cells
Eugenia Zah et al.
CANCER IMMUNOLOGY RESEARCH (2016)
A Mass Spectrometric-Derived Cell Surface Protein Atlas
Damaris Bausch-Fluck et al.
PLOS ONE (2015)
Analysis of the Human Tissue-specific Expression by Genome-wide Integration of Transcriptomics and Antibody-based Proteomics
Linn Fagerberg et al.
MOLECULAR & CELLULAR PROTEOMICS (2014)
Chimeric Antigen Receptor T Cells for Sustained Remissions in Leukemia
Shannon L. Maude et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Creation of a gated antibody as a conditionally functional synthetic protein
Smita B. Gunnoo et al.
NATURE COMMUNICATIONS (2014)
Combinatorial antigen recognition with balanced signaling promotes selective tumor eradication by engineered T cells
Christopher C. Kloss et al.
NATURE BIOTECHNOLOGY (2013)
The Cancer Genome Atlas Pan-Cancer analysis project
John N. Weinstein et al.
NATURE GENETICS (2013)
PD-1-and CTLA-4-Based Inhibitory Chimeric Antigen Receptors (iCARs) Divert Off-Target Immunotherapy Responses
Victor D. Fedorov et al.
SCIENCE TRANSLATIONAL MEDICINE (2013)
Gene-engineered T cells for cancer therapy
Michael H. Kershaw et al.
NATURE REVIEWS CANCER (2013)
Dual Targeting of ErbB2 and MUC1 in Breast Cancer Using Chimeric Antigen Receptors Engineered to Provide Complementary Signaling
Scott Wilkie et al.
JOURNAL OF CLINICAL IMMUNOLOGY (2012)
Preexistence and Clonal Selection of MET Amplification in EGFR Mutant NSCLC
Alexa B. Turke et al.
CANCER CELL (2010)
Case Report of a Serious Adverse Event Following the Administration of T Cells Transduced With a Chimeric Antigen Receptor Recognizing ERBB2
Richard A. Morgan et al.
MOLECULAR THERAPY (2010)
Sleeping beauty transposon-mediated engineering of human primary T cells for therapy of CD19(+) lymphoid malignancies
Xin Huang et al.
MOLECULAR THERAPY (2008)
piggyBac is a flexible and highly active transposon as compared to Sleeping Beauty, Tol2 and Mos1 in mammalian cells
Sareina Chiung-Yuan Wu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
A human protein atlas for normal and cancer tissues based on antibody proteomics
M Uhlén et al.
MOLECULAR & CELLULAR PROTEOMICS (2005)
Mammalian mutagenesis using a highly mobile somatic Sleeping Beauty transposon system
AJ Dupuy et al.
NATURE (2005)
Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemia.
BJ Druker et al.
NEW ENGLAND JOURNAL OF MEDICINE (2001)
Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2.
DJ Slamon et al.
NEW ENGLAND JOURNAL OF MEDICINE (2001)
Share Paper
